KZR vs REGN: Which Stock is Better?
Side-by-side comparison of Kezar Life Sciences Inc and Regeneron Pharmaceuticals Inc in 2026
KZR
Kezar Life Sciences Inc
$7.33
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | KZR | REGN | Winner |
|---|---|---|---|
| Market Cap | $54.33M | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze KZR
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KZR or REGN a better investment?
Comparing KZR and REGN: Kezar Life Sciences Inc has a market cap of $54.33M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KZR and REGN?
KZR (Kezar Life Sciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KZR or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KZR or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for KZR.
Which company is more profitable: KZR or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for KZR.
Which is the larger company: KZR or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $54.33M for KZR.
Should I buy KZR or REGN in 2026?
Both KZR and REGN have investment merit. KZR trades at $7.33 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KZR and REGN stock?
Key differences: Market Cap ($54.33M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).